Black Rose Industries Q4 FY26 earnings call: Revenue & Margins
Q4 FY26 earnings call: what management said on revenue, margins and capex.
- Revenue
- ₹104Cr
- +25.5% YoY
- +38.4% QoQ
- Net profit
- ₹9Cr
- +62% YoY
- +113.9% QoQ
- Margin
- 12.52%
- +2.2 pp YoY
- +3.8 pp QoQ
Guidance rank: #65 of 70 in Chemicals & Petrochemicals
See the sector's top 10 — free with your mobile number.
What the Q4 FY26 call signalled
1 of 3 strong
The short version
The company targets sustained growth in volumes and revenues through both distribution and manufacturing. The company aims for sustained growth with good margins overall for FY27, supported by increasing volumes and operational efficiencies.
From Black Rose Industries Ltd's Q4 FY26 earnings-call transcript · updated 23 Sept 2026.
Revenue & Sales Performance
- The company targets sustained growth in volumes and revenues through both distribution and manufacturing.
- New product additions in both segments are expected to drive topline growth.
- Capacity expansions and commercialization of pipeline projects (e.g., PAM solid) will add to volumes and revenues in FY27 and FY28.
- Export demand, particularly for acrylamide products, is picking up with registrations like REACH and KKDIK aiding market penetration.
- Market uncertainties remain, but the company is optimistic about increased utilization and sales despite global challenges.
- Initiatives to increase export sales, which generally have better profitability, are underway.
2 more points from Black Rose Industries Ltd's call on revenue
Create a free account to keep reading this call
Profitability & Margins
See what Black Rose Industries Ltd said on profitability & margins — free account, 30 seconds.
Capital Expenditure Plans
- PAM solid project has advanced to the piloting stage with commercialization expected during FY26.
- Specialty amines project is progressing as planned in collaboration with Koei Chemicals Company, with a decision anticipated during the current year.
- The company’s R&D team, based at the new laboratory in Navi Mumbai, is focused on new innovations and developing downstream acrylamide products to expand the manufacturing portfolio.
- Strategic shift away from ceramic binder business to focus on strengthening upstream acrylamide and higher-value applications.
2 more points from Black Rose Industries Ltd's call on capex
Create a free account to keep reading this call
Top-ranked in Chemicals & Petrochemicals
Ranked on what management guided this quarter
Rank buckets describe management commentary on revenue and margin. Not investment advice, and not a forecast of returns.
Fundraising & Capital Structure
See what Black Rose Industries Ltd said on fundraising & capital structure — free account, 30 seconds.
Order Book & Pipeline
2 more points from Black Rose Industries Ltd's call on order book
Create a free account to keep reading this call
Black Rose Industries Ltd — Quarterly revenue & net profit
Black Rose Industries Ltd Q4 FY26 results — key figures
| ₹ Cr | Q4 FY26 | Q4 FY25 | YoY | Q3 FY26 | QoQ |
|---|---|---|---|---|---|
| Revenue | 104 | 83 | +25.5% | 75 | +38.4% |
| Operating profit (EBITDA) | 13 | 9 | +52.8% | 7 | +99.5% |
| Operating margin | 12.52% | 10.29% | +2.2 pp | 8.69% | +3.8 pp |
| Profit before tax | 12 | 8 | +57.6% | 6 | +107.1% |
| Net profit (PAT) | 9 | 6 | +62% | 4 | +113.9% |
| EPS (₹) | 1.85 | 1.14 | +62.3% | 0.86 | +115.1% |
Source: reported quarterly figures (Screener), ₹ crore.
Reported quarterly figures (₹ Cr). Latest (Q4 FY26): revenue ₹104 Cr, net profit ₹9 Cr. Revenue and profit are scaled separately — hover a quarter for exact figures.
Full financials →Continue your research
What Black Rose Indus's management said in earlier quarters
Others in Chemicals & Petrochemicals this season
- Indian Phosphate (Q4 FY26)
H2 FY26 Revenue (Consolidated):** ₹580.25 Cr, up from ₹451.59 Cr in H2 FY25 — a year-on-year increase of ₹128.66 Cr. Key investor presentation takeaways from In
- Paragon Fine (Q4 FY26)
Revenue for H2FY26:** Rs 68.88 Cr, up 7.41% YoY from Rs 64.13 Cr in H2FY25 (Page 22). Key investor presentation takeaways from Paragon Fine's Q4 FY26 investor p
- IVP (Q4 FY26)
Q4 FY26 revenue from operations: ₹164.44 crore . Key investor presentation takeaways from IVP's Q4 FY26 investor presentation — and how it ranks against sector
- Vishnu Chemicals (Q4 FY26)
Q4 FY26 Operating Revenues: ₹450.3 crore, up 14.7% YoY from ₹392.6 crore in Q4 FY25 (Page 5). Key investor presentation takeaways from Vishnu Chemicals Ltd's Q4
Potential multibaggers · Q2 FY27
Potential multibaggers in Chemicals & Petrochemicals
on management's own guidance
- Strong growth2
- Strong growth1
- Strong growth3
Portfolio builder
Build your portfolio
from the top-ranked stocks
- 1. Pick 3–15 stocks
- 2. Choose large, mid or small cap and your sectors
- 3. Get a portfolio built from the rankings
Ranks describe management commentary on revenue and margin from the latest earnings call. Not investment advice.
Arthneeti Pro · Annual
Black Rose Industries Ltd and 15K+ more earnings calls,
for less than your morning chai
Every earnings call, ranking and concall Q&A across all four results seasons.
Secure Razorpay payment · instant access
Frequently Asked Questions
What were Black Rose Industries Ltd Q4 FY26 results?
The company targets sustained growth in volumes and revenues through both distribution and manufacturing. The company aims for sustained growth with good margins overall for FY27, supported by increasing volumes and operational efficiencies.
What is Black Rose Industries Ltd share price analysis?
Black Rose Industries Ltd currently shows a below-average growth signal. The stock trades at a P/E of 18.9 with a market cap of ₹543 Cr. Investors should review the full earnings analysis for detailed insights.
Is Black Rose Industries Ltd planning capital expenditure?
PAM solid project has advanced to the piloting stage with commercialization expected during FY26.
Keep Black Rose Industries Ltd on your radar — track it to get its next earnings analysis in your feed.
This analysis is AI-generated based on publicly available earnings data and the company's earnings call transcript. This is not investment advice. Please consult a SEBI-registered advisor before making investment decisions.
